EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy

Christoffer R Vissing iD, Anna Axelsson Raja iD, Adam S Helms iD, Sara Saberi iD, Anjali T Owens iD, Joseph W Rossano iD, Dominic J Abrams iD, Jodie Ingles iD, Belinda Gray iD, Rachel Lampert iD, John C Stendahl iD, Neal K Lakdawala iD und 10 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.076036 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, 2026. Verfasst von Christoffer R Vissing und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (C.R.V., A.A.R., H.B.). Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Sarcomeres. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sarcomere gene variants are a key cause of hypertrophic cardiomyopathy (HCM), and have been associated with worse prognosis. However, it is unclear how comorbidities influence clinical trajectories, the timing of events, and causes of death in sarcomeric and nonsarcomeric HCM. METHODS: We conducted a multicenter longitudinal cohort study of genotyped patients with HCM in the Sarcomeric Human Cardiomyopathy registry (SHaRe). Patients were classified as sarcomeric HCM (pathogenic/likely pathogenic sarcomere variant) or nonsarcomeric HCM (genetically elusive). The influence of genetic classification and comorbidities on the sequence of cardiovascular events were assessed in time-varying Cox proportional hazards models. RESULTS: Among 6120 patients (40% women; 87% probands; 50% sarcomeric HCM), followed for a median of 5.3 years, sarcomeric HCM (n=3082) was associated with a younger age at diagnosis (median 38.1 versus 54.3 years; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicSarcomeresAdultAgedFemaleHumansMaleMiddle AgedCohort StudiesComorbidityLongitudinal StudiesRegistriesRisk Factors

Stichwörter der Autor:innen

atrial fibrillationgeneticsheart failurehypertrophic cardiomyopathymortalityventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (C.R.V., A.A.R., H.B.).
  • Department of Cardiology, Hvidovre Hospital, Copenhagen University Hospital, Denmark (C.R.V.).
  • Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (A.S.H., S.S.).
  • Division of Cardiology, University of Pennsylvania, PA (A.T.O., S.M.D.).
  • Center for Cardiovascular Genetics, Department of Cardiology, Boston Children's Hospital & Harvard Medical School, Boston, MA (D.J.A).
  • Genomics and Inherited Disease Program, Garvan Institute of Medical Research and University of New South Wales, Sydney, Australia (J.I.).

ORCID-Profile: Christoffer R Vissing, Anna Axelsson Raja, Adam S Helms, Sara Saberi, Anjali T Owens, Joseph W Rossano, Dominic J Abrams, Jodie Ingles, Belinda Gray, Rachel Lampert, John C Stendahl, Neal K Lakdawala, James S Ware, Victoria N Parikh, Michelle Michels, Lia Crotti, Thomas D Ryan, Iacopo Olivotto, Sharlene M Day, Henning Bundgaard, Brian L Claggett, Carolyn Y Ho

Zitieren

APA

Vissing, C. R., Axelsson Raja, A., Helms, A. S., Saberi, S., Owens, A. T., Rossano, J. W., Abrams, D. J., Ingles, J., Gray, B., Lampert, R., Stendahl, J. C., Lakdawala, N. K., Ware, J. S., Parikh, V. N., Michels, M., Crotti, L., Ryan, T. D., Olivotto, I., Day, S. M., …, & Ho, C. Y. (2026). Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy. Circulation. https://doi.org/10.1161/circulationaha.125.076036

Vancouver

Vissing CR, Axelsson Raja A, Helms AS, Saberi S, Owens AT, Rossano JW, et al. Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy. Circulation. 2026. doi:10.1161/circulationaha.125.076036

BibTeX
@article{Vissing2026,
  author = {Vissing, Christoffer R and Axelsson Raja, Anna and Helms, Adam S and Saberi, Sara and Owens, Anjali T and Rossano, Joseph W and Abrams, Dominic J and Ingles, Jodie and Gray, Belinda and Lampert, Rachel and Stendahl, John C and Lakdawala, Neal K and Ware, James S and Parikh, Victoria N and Michels, Michelle and Crotti, Lia and Ryan, Thomas D and Olivotto, Iacopo and Day, Sharlene M and Bundgaard, Henning and Claggett, Brian L and Ho, Carolyn Y},
  title = {Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.076036}
}
Kostenlos starten →